Company Filing History:
2 out of 15 
1 out of 25 Years Active: 2019-2023
Title: The Innovative Contributions of JinWon Jung
Introduction
JinWon Jung, an accomplished inventor based in Daejeon, South Korea, has made significant strides in the field of biotechnology. With a total of two patents to his name, Jung has demonstrated a commitment to advancing medical science, particularly in cancer treatment and therapeutic applications.
Latest Patents
Jung's latest patents showcase groundbreaking innovations. The first patent, titled “Antibody-drug conjugate comprising antibody against human ROR1 and use for the same,” reveals an innovative approach to treating diseases associated with the over-expression of ROR1, including various forms of cancer. This invention emphasizes the development of antibody-drug conjugates (ADCs) that target ROR1, along with methods for their preparation and clinical applications.
The second patent, “Dual-targeting protein binding specifically to DLL4 and VEGF and use thereof,” introduces a novel dual-targeting protein that specifically binds to delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). This innovation holds promise for improved therapeutic strategies in treating diseases influenced by these critical proteins.
Career Highlights
Throughout his career, JinWon Jung has been affiliated with leading biotechnology companies, notably Abl Bio Inc. and Legochem Biosciences, Inc. His work in these organizations has contributed to the advancement of innovative treatments and has positioned him as a notable figure in the biotech industry.
Collaborations
In addition to his individual achievements, Jung has collaborated with esteemed colleagues such as Dong Heon Lee and Kyung Duk Moon. These collaborations have enriched his research efforts and expanded his contributions to the scientific community.
Conclusion
JinWon Jung's inventions exemplify the spirit of innovation in the field of biotechnology. With his focus on developing targeted therapies, he continues to contribute valuable insights and advancements that could lead to effective treatments for cancer and other serious diseases. His work not only highlights the potential of modern medicine but also emphasizes the importance of collaboration and innovation in driving scientific progress.